Kyle Faget Authors Article on ‘Compliance Considerations for Entities Providing Hybrid Clinical Trial Services’
28 April 2022
Journal of Health Care Compliance
Foley & Lardner LLP Partner Kyle Faget authored the article, “Compliance Considerations for Entities Providing Hybrid Clinical Trial Services,” for the March-April 2022 issue of the Journal of Health Care Compliance. In the article, she discusses how clinical trials are leveraging telehealth, the new business model of hybrid clinical trial services, and compliance considerations that should be addressed to enter the market safely.
People
Related News
20 September 2024
In the News
David Rosen Featured for Insight on Looming FDA Final Rule for Cosmetic Manufacturing
Foley & Lardner LLP partner David Rosen is featured by CosmeticsDesign for his insights on the U.S. Food and Drug Administration's final rule establishing Good Manufacturing Practices for the cosmetics industry in the article, "Preparing for MoCRA’s 2025 cGMP deadline: What cosmetic manufacturers and suppliers need to know."
19 September 2024
In the News
Patrick Daugherty on UChicago's Desk Reference for Crypto, Web3 – 'This is very much for lawyers'
Foley & Lardner LLP partner Patrick Daugherty commented on the University of Chicago Law School's recently released open-access legal desk reference on crypto and Web3 matters in the Law.com article, "UChicago Law Professors Release Desk Reference Breaking Down Crypto, Web 3 for Attorneys."
18 September 2024
In the News
Eli Mazour Talks Patents on IPWatchdog Unleashed Podcast
Foley & Lardner of counsel Eli Mazour appeared on the IPWatchdog Unleashed podcast episode, "Problems, Solutions and the Case for Patents," to discuss patents and innovation, the Federal Circuit, the value of patents to clients, and patent strategy.